Modal close

Dear Democracy Now! visitor,

You turn to Democracy Now! for ad-free news you can trust. Maybe you come for our daily headlines. Maybe you come for in-depth stories that expose corporate and government abuses of power. Democracy Now! brings you crucial reporting like our coverage from the front lines of the standoff at Standing Rock or news about the movements fighting for peace, racial and economic justice, immigrant rights and LGBTQ equality. We produce our daily news hour at a fraction of the budget of a commercial news operation—all without ads, government funding or corporate sponsorship. How is this possible? Only with your support. If every visitor to this site in December gave just $10 we could cover our basic operating costs for 2017. Pretty exciting, right? So, if you've been waiting to make your contribution to Democracy Now!, today is your day. It takes just a couple of minutes to make sure that Democracy Now! is there for you and everybody else in 2017.

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Topics

13th Amendment Blocks Patents on Stem Cell and Cloning Technologies

StoryAugust 21, 2001
Watch iconWatch Full Show

Guests
Carlos Eugenio Vargas

Lawyer for Coopetrabasur and board member of Agrofair.

Yocser Carranza Godoy

Banana farmer from Costa Rica. He is President of the worker-controlled cooperative called coopetrabasur.

As research in the areas of stem cells and cloning continues to progress, various American and European biotechnology companies are racing to patent new techniques and technologies. However, they are running into barriers in the form of laws against the ownership of human beings. In the US, the 13th Amendment, which was drafted to abolish slavery and outlaws the ownership of people, makes the language of more ambiguous patents troublesome because of references to the cloning of "animals," including humans. Europe also has universal bans on the patenting of technology related to the cloning of humans, but the European patent office has made a number of errors allowing for such procedures to become privatized in the past.


The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.

Make a donation